Triple

T10214782
Position Surface form Disambiguated ID Type / Status
Subject CYP3A4 E242412 entity
Predicate inducedBy P92780 FINISHED
Object carbamazepine
Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
 E850013 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: carbamazepine | Statement: [CYP3A4, inducedBy, carbamazepine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: carbamazepine
Context triple: [CYP3A4, inducedBy, carbamazepine]
  • A. phenytoin
    Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
  • B. Lyrica
    Lyrica is a prescription medication (pregabalin) commonly used to treat nerve pain, fibromyalgia, and certain types of seizures.
  • C. Acurenam
    Acurenam is a town located in the Centro Sur province of Equatorial Guinea.
  • D. Symmetrel
    Symmetrel is a brand-name antiviral and antiparkinsonian medication whose active ingredient is amantadine.
  • E. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: carbamazepine
Triple: [CYP3A4, inducedBy, carbamazepine]
Generated description
Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: carbamazepine
Target entity description: Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • A. phenytoin
    Phenytoin is an antiepileptic medication commonly used to prevent and control seizures by stabilizing neuronal activity in the brain.
  • B. Lyrica
    Lyrica is a prescription medication (pregabalin) commonly used to treat nerve pain, fibromyalgia, and certain types of seizures.
  • C. Acurenam
    Acurenam is a town located in the Centro Sur province of Equatorial Guinea.
  • D. Symmetrel
    Symmetrel is a brand-name antiviral and antiparkinsonian medication whose active ingredient is amantadine.
  • E. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d381ae26c48190985abd0e25ee5d04 completed April 6, 2026, 9:49 a.m.
NER Named-entity recognition batch_69d4d1f860048190bb20f7d3bf87f347 completed April 7, 2026, 9:44 a.m.
NED1 Entity disambiguation (via context triple) batch_69d652ea80dc81908bc65ee2ec390467 completed April 8, 2026, 1:06 p.m.
NEDg Description generation batch_69d657818b008190a24170717cff53b9 completed April 8, 2026, 1:26 p.m.
NED2 Entity disambiguation (via description) batch_69d65835a11c819083d069ab0f644d4c completed April 8, 2026, 1:29 p.m.
Created at: April 6, 2026, 11:04 a.m.